Dentsply International | XRAY - Ebit

Aktienkurs
11.91
Täglich Wechseln
0.01 0.08%
Monatlich
1.97%
Jährlich
-13.38%
Q2 Prognose
11.66




Ebit Veränderung Datum
3M USD 1.55B 337M 2026-03
Agilent USD 353M 90M 2025-12
Align Technology USD 224.71M 40.06M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Cardinal Health USD 763M 9M 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
CVS Health USD 2.11B 836M 2025-12
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 538M 26M 2025-12
Henry Schein USD 186M 12M 2025-12
Idexx Laboratories USD 315.6M 39.24M 2025-12
Illumina USD 256M 6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
IQVIA Holdings USD 2.68B 2.1B 2025-12
McKesson USD 1.66B 159M 2025-12
Medtronic USD 1.74B 40M 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Owens Minor USD 814K 28.08M 2025-12
Repligen USD 19.97M 3.16M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Smith & Nephew USD 440M 50M 2025-12
Stryker USD 1.97B 609M 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Veradigm USD -45.47M 70.47M 2022-12
Waters USD 270.52M 78.4M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12
Zoetis USD 835M 140M 2025-12